Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
9.55
13.36
|
Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one PNVL3 stock under the Base Case scenario is 16.71 BRL. Compared to the current market price of 9.58 BRL, Dimed SA Distribuidora de Medicamentos is Undervalued by 43%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Dimed SA Distribuidora de Medicamentos
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for PNVL3 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Dimed SA Distribuidora de Medicamentos
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Dimed SA Distribuidora de Medicamentos
Balance Sheet Decomposition
Dimed SA Distribuidora de Medicamentos
Current Assets | 1.9B |
Cash & Short-Term Investments | 270.6m |
Receivables | 556.3m |
Other Current Assets | 1.1B |
Non-Current Assets | 1.3B |
PP&E | 1.1B |
Intangibles | 89.3m |
Other Non-Current Assets | 88.6m |
Current Liabilities | 1.2B |
Accounts Payable | 559.4m |
Accrued Liabilities | 174.7m |
Other Current Liabilities | 459.2m |
Non-Current Liabilities | 781.8m |
Long-Term Debt | 766.6m |
Other Non-Current Liabilities | 15.2m |
Earnings Waterfall
Dimed SA Distribuidora de Medicamentos
Revenue
|
4.7B
BRL
|
Cost of Revenue
|
-3.2B
BRL
|
Gross Profit
|
1.5B
BRL
|
Operating Expenses
|
-1.3B
BRL
|
Operating Income
|
159.9m
BRL
|
Other Expenses
|
-68.6m
BRL
|
Net Income
|
91.3m
BRL
|
Free Cash Flow Analysis
Dimed SA Distribuidora de Medicamentos
BRL | |
Free Cash Flow | BRL |
PNVL3 Profitability Score
Profitability Due Diligence
Dimed SA Distribuidora de Medicamentos's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Dimed SA Distribuidora de Medicamentos's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
PNVL3 Solvency Score
Solvency Due Diligence
Dimed SA Distribuidora de Medicamentos's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Score
Dimed SA Distribuidora de Medicamentos's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PNVL3 Price Targets Summary
Dimed SA Distribuidora de Medicamentos
According to Wall Street analysts, the average 1-year price target for PNVL3 is 14.28 BRL with a low forecast of 13.13 BRL and a high forecast of 15.75 BRL.
Dividends
Current shareholder yield for PNVL3 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Dimed SA Distribuidora de Medicamentos engages in the marketing, distribution and sale of medicines and cosmetics. The company is headquartered in Eldorado Do Sul, Rio Grande Do Sul and currently employs 9,414 full-time employees. The Company, along with its subsidiaries, sells, distributes, imports, exports and produces a variety of products, including drugs, perfumes, cosmetics, dermo-cosmetics, personal care products, dietary supplements, and fitness, orthopedic and physiotherapy accessories. The company organizes its business into two main segments: Medicine and Perfumery. The firm provides retail and wholesale distribution. The firm owns distribution centers in Brazilian states of Rio Grande do Sul, Santa Catarina, Parana, Goias and Espirito Santo, as well as over 280 stores in states of Rio Grande do Sul, Santa Catarina and Parana.
Contact
IPO
Employees
Officers
The intrinsic value of one PNVL3 stock under the Base Case scenario is 16.71 BRL.
Compared to the current market price of 9.58 BRL, Dimed SA Distribuidora de Medicamentos is Undervalued by 43%.